Table 7. Validated methods for antimony quantification in human samples.
Anodic stripping voltammetry | Inductively coupled plasma mass spectrometry and on-line ion chromatography | Graphite furnace atomic absorption | Electrothermal atomic absorption Spectroscopy | Hydride generation atomic fluorescence spectrometry | Inductively coupled plasma mass spectrometry | |
---|---|---|---|---|---|---|
Sample | Heparinized blood | Heparinized blood, plasma, urine, hair | Urine | Plasma, urine | Hair | Plasma, PBMCs |
Amount of biological sample | 5 ml | Blood, plasma and urine: ND† Hair: 0.5–2.0 cm length (measured from the scalp) | 2g | ND | 0.5 g | Plasma: 100 μl PBMCs: 2.27 ×106–25.7 ×106 cells |
Extraction or digestion methods | ND† | Blood, plasma and urine: ND† Hair: nitric acid and hydrogen peroxide | Chelation with thenoyl-trifluoro-acetone in supercritical carbon dioxide | Nickelous nitrate hexahydrate in nitric acid and Triton X-100 | Nitiric acid, hydrochloric acid and water in closed system | 1% TMAH/1% EDTA |
LLOQ | 76 ng/ml | 0.16 ng/ml for SbV 0.15 ng/ml for SbIII |
12.5 ng/ml | 20 ng/ml | 4.6 ng/g | 25 ng/ml |
CV at lowest quantification | 1.3–3.4 % | 0.9985 (R2) for SbV 0.9989 (R2) for SbIII |
2.8% (RSD) | 11.1% | 2.8% (RSD) | Plasma: 5.16% PBMCs: 8.88% |
Quantification range of Sb concentrations | 76–29,500 ng/ml | 0–100 ng/ml for both SbV and SbIII |
2.5–200 ng/ml | 0–200 ng/ml | ND† | 25–10000 ng/ml |
SbV and SbIII speciation | No | Yes | No | No | No | No |
Reference | Chulay JD et al. (1988) [27] | Miekeley N etal. (2002) [12] | Hui-Ming L (2013) [28] | Cruz A et al. (2007) [11], de Aguilar MG et al. (2018) [29] | Cardozo MC et al. (2016) [30] | Current study |
LLOQ: Lower limit of quantification; ND: Not described; PBMC: Peripheral blood mononuclear cell; TMAH: Tetramethylammonium hydroxide.